Host: Pavani Chalasani, MD, MPH
Guest: Hope S. Rugo, MD, FASCO
Results from the TROPiCS-02 trial may impact survival for patients with receptor–positive/HER2-negative breast cancer. To find out why, Dr. Hope Rugo from the University of California San Francisco Comprehensive Cancer Center joins Dr. Pavani Chalasani to talk about the study and how it might impact the future of breast cancer treatment.
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More